ArticleJCI insight2022

Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients.

Eva Schrezenmeier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.